All Type of News
Insults on Korean new drugs, 4 of 29 approval drugs suspended in manufacturing
Starting SK Chemicals’ ‘Sunpla Inj’ in 1999, the total 29 Korean new drugs have been approved, but 4 of them were thrown out from the market for reasons, such as poor sales.
According to the Ministry of Food and Drug...
Celltrion Chairman Jung-Jin Seo will reveal pipelines to be developed by 2030Celltrion Chairman Jung-Jin Seo will reveal its pipelines at the 2018 Celltrion Healthcare International Summit in Venice, Italy between the 8th and 9th of February.
The Celltr...
|
Large event will open to introduce healthcare and medical devices from EU
The European Union(EU) announced to hold the ‘EU Gateway Healthcare and Medical Technologies’ exhibition which introduced the European Union’s advanced healthcare technologies and medical devices at InterContinental S...
Ms. Sun-Hye Cho selected as 35th KPDA President
At the 35th Korea Pharmaceutical Distribution Association(KPDA) Presidential Election, Candidate Sun-Hey Cho was elected with the support from 57.4% of the voters.
The KPDA held the 56th regular general meeting at Sh...
Novartis rebate case, how far PMs could do?As it seemed PMs for marketing have exchanged money directly with the media companies involved with the Novartis’ rebate case, the people are focusing on the relations among the...
|
Why people are looking forward to the ‘Belkyra’ release?
Allergan Korea has started to take a new leap using its new products.
The company held the media day on journalists of the health care field on the 7th and introduced new products which will lead the company’s growth...
Sanofi, “We’ll start 2 new Phase III clinical trials of Hanmi’s efpeglenatide this year”
Hanmi Pharm(CEO Sae-Chang Kwon, Jong-Soo Woo) will conduct 2 more new Phase III clinical trials to increase the value of efpeglenatide, a new antidiabetic biologic.
A partnering company of Hanmi Pharm, Sanofi announc...
KCDC-CJ sign technology transfer agreement of hand-foot and mouth disease vaccine worth of KRW 2.2 billion
The Korea Centers for Disease Control and Prevention(KCDC) Korea National Institute of Health(President Do-Joon Park) will sign a technology transfer agreement of a preventive hand-foot and mouth disease injectable va...
“Adopting QbD is not a choice, but requirement for pharma industry”
As a method to narrow the technology gap against pharmaceutically-advanced countries and increase the Korea’s national competitiveness of medicines developed in Korea, the Ministry of Food and Drug Safety(MFDS) will a...
Government’s plans to intensively raise pharma & biotech industry
Minister Neung-Hoo Park announced the government’s plan intensively raise the pharmaceutical, biotechnology and medical device industries as the future new industries, stressing their strong points, such as the health...
